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Abstract
Background: Albendazole (ABZ), a benzimidazole (BZ) anthelmintic (AH), is commonly used for treatment of soil-
transmitted helminths (STHs). Its regular use increases the possibility that BZ resistance may develop, which, in veterinary
nematodes is caused by single nucleotide polymorphisms (SNPs) in the b-tubulin gene at positions 200, 167 or 198. The
relative importance of these SNPs varies among the different parasitic nematodes of animals studied to date, and it is
currently unknown whether any of these are influencing BZ efficacy against STHs in humans. We assessed ABZ efficacy and
SNP frequencies before and after treatment of Ascaris lumbricoides, Trichuris trichiura and hookworm infections.
Methods: Studies were performed in Haiti, Kenya, and Panama. Stool samples were examined prior to ABZ treatment and
two weeks (Haiti), one week (Kenya) and three weeks (Panama) after treatment to determine egg reduction rate (ERR). Eggs
were genotyped and frequencies of each SNP assessed.
Findings: In T. trichiura, polymorphism was detected at codon 200. Following treatment, there was a significant increase,
from 3.1% to 55.3%, of homozygous resistance-type in Haiti, and from 51.3% to 67.8% in Kenya (ERRs were 49.7% and
10.1%, respectively). In A. lumbricoides, a SNP at position 167 was identified at high frequency, both before and after
treatment, but ABZ efficacy remained high. In hookworms from Kenya we identified the resistance-associated SNP at
position 200 at low frequency before and after treatment while ERR values indicated good drug efficacy.
Conclusion: Albendazole was effective for A. lumbricoides and hookworms. However, ABZ exerts a selection pressure on the
b-tubulin gene at position 200 in T. trichiura, possibly explaining only moderate ABZ efficacy against this parasite. In A.
lumbricoides, the codon 167 polymorphism seemed not to affect drug efficacy whilst the polymorphism at codon 200 in
hookworms was at such low frequency that conclusions cannot be drawn.
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Introduction
Ascaris lumbricoides (roundworm), Trichuris trichiura (whipworm)
and Necator americanus/Ancylostoma duodenale (hookworms) are the
most common species of soil-transmitted helminths infecting
humans worldwide. More than a billion people are infected with
at least one species and 300 million are estimated to have severe
infections with more than one of these parasites [1]. These
infections are endemic in tropical and sub-tropical regions of the
developing world and are associated with poverty, lack of clean
water, and poor sanitation [2]. School-age children are the most at
risk of infection with STHs and early childhood infections
contribute significantly to debilitation [3]. Infected children can
be malnourished and experience stunting growth and intellectual
retardation, with cognitive and educational deficits [1]. Because of
all these characteristics and according to estimates by the World
Health Organization (WHO) [4], STHs are included in the group
of the so-called neglected tropical diseases (NTDs). The main
intervention to control STH infections at a community level is
based on periodic mass drug administration (MDA) of the
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benzimidazole (BZ) anthelmintic (AH) drugs, albendazole (ABZ)
or mebendazole (MBZ) [5], that reduce the prevalence and
intensity of infections [6]. However large-scale chemotherapy
programmes with these drugs have the potential to exert selection
pressures on the causing parasites, which may favour the
development of drug resistance. Recently, expansion of MDA
programmes for STHs have highlighted the need to monitor for
the possibility that resistance may develop [7,8]. This development
would have important adverse consequences on the benefits
provided by deworming programmes [9,10]. BZ resistance in
other parasitic nematodes is caused by a single nucleotide
polymorphism (SNP) in the b-tubulin gene at codon positions
200 (TRA), 167 (TRA), or 198 (ARC) [11–13]. The frequency
and relative importance of these different SNPs varies among the
nematode species studied to date [13–15]. Molecular markers have
been developed to identify SNPs in A. lumbricoides, T. trichiura and
hookworms and wild-type and mutant-type control plasmids have
been constructed to obtain the genotype profiles of ‘‘susceptible-
type’’ parasites (which do not have mutations at position 200, 167
and 198) and ‘‘mutant-type’’ parasites (that contain mutations in
one of these three positions) [16]. The codon 200 polymorphism
has been identified in T. trichiura populations collected from
untreated subjects in Kenya and from treated subjects in Panama
[17], and in hookworms collected in Haiti in an area periodically
treated with ABZ [16]. In the present report, our aim was to
investigate the field efficacy of ABZ against STH infections in
countries where polymorphism in b-tubulin had previously been
identified, and to assess the frequency of each SNP prior to, and
after ABZ treatment within each country and for each of the three
main nematode species.
Materials and Methods
Study Design and Study Areas in Haiti, Kenya and
Panama
Three cross-sectional studies were carried out between 2008
and 2010 in three countries located in different geographical areas,
including Haiti in the Caribbean, Kenya in East Africa and
Panama in Central America. These studies were integrated into
the following control and evaluation programmes of ABZ use: a
national health programme to fight lymphatic filariasis (LF) and
intestinal worms in Haiti (in collaboration with the Hoˆpital Ste.
Croix and the Centers for Disease Control (CDC)); school health
and nutrition programmes in Kenya, and health and nutrition
programmes in Panama. Thus, each study included a treatment
with ABZ, stool examinations, and genotyping of the b-tubulin
gene in eggs collected before and after ABZ treatment to assess the
drug efficacy against STHs and to examine at each time point the
frequency of possible SNPs associated with ABZ resistance in
nematodes of veterinary importance. The study designs in Kenya,
Panama and Haiti (Figure 1) were different because each study
was part of a separate national and local MDA programme. Thus,
different protocols were applied rather than a purposely designed
multi-study site single protocol.
Study in Haiti
The study in Haiti included stool collections prior to, and after a
drug treatment given in 2009. In Haiti, the study sites were located
in the West and Southeast Haitian departments known to be naive
for MDA with ABZ. Individuals from five endemic communities
who reached the inclusion criterion (older than two years old) were
randomly selected. All potential participants were informed by a
trained community leader of the purpose and methods of the study
and gave their oral consent (in the case of children, consent was
obtained from a parent). A total of 353 stool samples were
collected and analyzed prior to ABZ treatment. Treatment was
then distributed to all people of each community (400 mg ABZ
and 6 mg/kg diethylcarbamazine (DEC)). ABZ was supplied as a
donation from GlaxoSmithKline (GSK). Participants in the study
were not observed during the treatment administration. However,
the compliance to treatment was evaluated post-treatment by a
questionnaire and relied on self-reported information of each
participant, and on pre and post-treatment egg counts. Samples
from participants who were not treated with ABZ were not
included in the analysis. Follow-up faecal samples (n = 317) were
collected two weeks after the drug treatment.
Study in Kenya
School-aged children from two schools located in Kwale District
were enrolled in the study. Although the schools were selected
because at the time of the study they were not involved in any
other STH deworming programmes, pupils had received ABZ and
DEC six month prior to our study for LF treatment. Stool samples
were collected prior to ABZ treatment in both schools (n = 128)
and then all children received 400 mg ABZ under the supervision
of the school teachers. The drug was provided by the Kenyan
Ministry of Health and was manufactured by GSK. Seven days
later, a follow-up collection was undertaken (n = 92). In one of the
schools, the stool collections before and after ABZ treatment were
done over two consecutive days and the results averaged.
Study in Panama
The field study was conducted in the region of Comarca Nga¨be-
Bugle´ [18]. Stool samples were collected from pre-school children
at different time points over a period of 16 months from July 2008
to October 2009. Two treatments with ABZ, as a suspension
(200 mg: one to two years of age; 400 mg: three to five years of
age) were distributed, once in 2008 and the second. nine months
later in 2009 [19]. The drug was provided by the Panamanian
Ministry of Health. In the present study, we only analyzed the
faecal samples collected prior to treatment and three weeks after
Author Summary
The soil-transmitted helminths (STH) Ascaris lumbricoides,
Trichuris trichiura and the hookworms Ancylostoma duo-
denale and Necator americanus are endemic in many
tropical countries. Regular treatment with albendazole or
mebendazole is the major means for controlling STHs.
However, repeated treatment with the same class of
benzimidazole anthelmintics has caused resistance in
veterinary parasites, characterized by mutations at either
codon 200, 167 or 198 in the b-tubulin gene. There is a
concern that resistance may develop in human STH. Drug
efficacy and mutation frequencies were assessed in T.
trichiura, A. lumbricoides and hookworms collected in Haiti,
Kenya and Panama prior to and after albendazole
treatment. In T. trichiura from Haiti and Kenya, a significant
increase of the frequency of the mutation at codon 200
was identified after treatment and drug efficacy was
mediocre. Against A. lumbricoides, albendazole efficacy
was good, even though the frequency of a mutation at
codon 167 was relatively high, suggesting that, in this
nematode, the codon 167 polymorphism does not impact
efficacy. In hookworms, the mutation at codon 200 was
identified, but at low frequencies and the response to
albendazole was good. We conclude that monitoring for
possible resistance in control programmes should be
undertaken.
Albendazole for STHs Control and b-Tubulin SNPs
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Figure 1. Flow chart of the study designs in Haiti, Kenya and Panama. *The number of eggs genotyped is different from the number of eggs
collected. This is due to failures in DNA extraction, PCR amplification or Pyrosequencing. x¯ represents the mean number of eggs sampled per host;
SD= standard deviation. The dashed lines mean that the connection between the two boxes is not direct.
doi:10.1371/journal.pntd.0002247.g001
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treatment in 2009 since the baseline prevalence for STHs was very
low in the 2008 samples. Prior to this second ABZ treatment, stool
samples were collected from 270 pre-school aged children and
follow-up samples were available from 222 children. Children
were observed while received the ABZ treatment, and only
samples from treated children were included in the analysis.
Ethics Statement
In the three studies, all instances of consent were informed.
Ethical approval for Haiti was obtained from the Institutional
Review Board of the Centers for Diseases Control and Prevention,
Atlanta, Georgia, US (Dr. Patrick Lammie), and the Ethics
Committee of the Hoˆpital Ste Croix, Haiti and included the
collection of stool samples, examination of stool samples for
helminth eggs and DNA analysis of helminth eggs.
Informed consent was obtained from all adult participants and
from parents or legal guardians of all minors. A parent or legal
guardian gave consent in every case of child participation. Based
on past experience, it was likely that some people in the
communities would not be able to read. A waiver of written
informed consent on the basis that the research presented no more
than minimal risk of harm to the subjects and involved no
procedures for which written consent is normally required outside
the research context in this setting, was requested and approved.
The use of oral consent was previously approved by the IRB.
Subjects were offered a written copy of the IRB approved consent
form. The contents of the approved consent form were explained
to each household, following which verbal consent was obtained.
The reader of the consent form and a witness signed a copy of the
form to indicate the subject’s agreement.
The study in Kenya was approved by the Kenya Medical
Research Institute (KEMRI) Ethical Review Committee. The
informed consent process, which was approved by the KEMRI
IRB specifically stated that the study was included in the national
programme on surveillance of disease control and followed
established government procedure. The school heads organized
meetings with their parent teacher association to obtain agreement
for the project. An information sheet was provided. It was
emphasized that the participation in the study by children was
voluntary and that they may refuse to participate. All children
were treated with ABZ and praziquantel in the study. Finally, all
samples were anonymised. As part of a national control
programme, informed consent was not documented for each
individual. The content of the study was verbally explained in
detail to parents/guardians, teachers and children from each
school. It was done orally as it was necessary to have this explained
in local languages. The use of oral consent was previously
approved by the IRB. A parent or legal guardian gave oral
informed consent in every case of child participation.
The study in Panama was approved by the McGill University
Review Board in Canada, the Instituto Conmemorativo de Gorgas
and local indigenous leaders in Panama. Written informed consent
was obtained from primary caregivers for their own participation
as well as that of their children. They were provided with an
explanation of the study, its significance, and of participant
requirements and rights. They were given an opportunity to ask
questions in Spanish and in the local language. A parent or legal
guardian gave consent in every case of child participation.
Stool Sample Procedure and Examination
In all studies and for each intervention (before and after ABZ
treatment), labelled containers were distributed to each participant
and collected the following morning from the community leader in
Haiti, schools in Kenya, and each participant’s home in Panama.
Three diagnostic techniques: McMaster, Kato-Katz, and FLO-
TAC were used to identify STH eggs and determine the number
of egg per gram (epg) in the faecal material collected before and
after ABZ treatment.
In Haiti we used a modified McMaster technique on each
collected sample. One gram of faeces was suspended with water
and the solution was stirred until it was completely broken apart.
The mixture was poured through surgical gauze into a centrifuge
tube. After centrifugation for 10 min at 15,000 rpm, the
supernatant was poured off and the tube containing the sediment
was filled with saturated sucrose solution and then gently stirred.
After 10 min, an aliquot of the flotation fluid from the upper
surface of the solution was transferred into each compartment of a
McMaster chamber. The eggs were counted in both chambers
using a low power objective (610). The number of epg of faeces
was obtained by multiplying the total number of eggs counted in
the two chambers by 50 [20].
In Kenya, the McMaster (as described above) and Kato-Katz
techniques [21] were used on samples from one school and Kato-
Katz alone was used in the other school. For Kato-Katz, the
number of eggs counted was multiplied by 24 to obtain the epg
[21].
In Panama, the identification of eggs and the assessment of epg
were performed using Kato-Katz [21] and FLOTAC [22,23], as
previously described [19].
One of the primary objectives of the study was to assess the
frequency of SNPs associated with resistance to ABZ (seen in the
veterinary nematode Haemonchus contortus) in the b-tubulin gene of
STHs collected from untreated and treated subjects. Thus, from
the three studies, eggs from positive subjects were recovered using
a saturated sucrose solution with centrifugation, and recovered
eggs were preserved in 70% alcohol until use for molecular
analysis.
Examination of the b-tubulin Gene and Assessment of
SNPs
DNA Isolation from Individual Eggs of STHs. Eggs
previously preserved in 70% alcohol were washed in distilled
water and separated by species under a dissecting microscope.
Individual eggs were isolated with a 10 ml pipette and then placed
into a PCR tube. Genomic DNA of each individual egg was then
extracted according to a protocol elaborated by Lake and
colleagues [24] and adapted to STHs. One hundred millilitres of
lysis buffer (50 mM KCl, 10 mM Tris pH 8.3, 2.5 mM MgCl2,
0.45% Nodidet P-40, 0.45% Tween 20, 0.01% gelatine) was
previously prepared, and an aliquot of 1 ml of this lysis buffer was
taken to which 10 ml proteinase K (10 mg/ml) and 10 ml b-
mercaptoethanol (Sigma-Aldrich, St Louis, MO, USA) were
added. The solution of lysis buffer with proteinase K and b-
mercaptoethanol was placed at 220uC for one week. Individual
eggs were placed into a labelled PCR tube and 15 ml of the
mixture was added. The tube was subsequently frozen at 280uC
for 30 min and then incubated at 60uC for 2 h. This procedure of
freezing and heating the egg solution helps the digestion of the
eggshell to facilitate DNA extraction. The proteinase K was
inactivated by heating to 94uC for 15 min.
Genotyping of b-tubulin Gene Positions 167, 198 and 200
in A. lumbricoides, T. trichiura and Hookworms. After
DNA extraction, all samples were subjected to PCR to amplify
small fragments surrounding the SNP at codon positions 167, 198,
and 200 in the b-tubulin genes of A. lumbricoides (FJ501301.1,
GenBank acc. number), T. trichiura (AF034219.1 GenBank acc.
number) and hookworms (EF392851.1 GenBank acc. number). All
primers used for genotyping with the Pyrosequencer were designed
Albendazole for STHs Control and b-Tubulin SNPs
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with the PyroMark Assay Design Software (Qiagen, version 2.0) to
amplify single egg DNA. To allow for nested PCRs on single eggs,
some primers were different from those used in our previous study
[17] in which the DNA concentrations were higher. For PCR, 2 ml
of lysate was used as template in a 20 ml reaction containing 2 ml
106PCR buffer, 1 ml [50 mM] MgSO4, 1 unit Platinum Taq
DNA Polymerase High Fidelity, 1 ml of sense and antisense
primers [10 mM] (details in Supplementary Table S1) 1 ml dNTP
mix [10 mM], and distilled water to 20 ml. PCR reactions were
performed with the following cycling parameters: 94uC for 3 min
followed by 30 cycles of 94uC, 59uC for 45 s and 68uC for 1 min
with a final extension step at 68uC for 5 min. A second PCR
reaction using the earlier PCR product as template was necessary
to visualize the product on an agarose gel. The reaction contained
5 ml 106PCR buffer, 2 ml [50 mM] MgSO4, 1 unit Platinum Taq
DNA Polymerase High Fidelity, 1 ml of sense and antisense
primers [10 mM], 1 ml dNTP mix [10 mM], and distilled water to
give a final volume of 50 ml. The same primers were used for each
species amplified except for the antisense primer for codon
position 198–200 of A. lumbricoides (59 CAGATGTCGTA-
CAAAGCCTCATT 39, position). For genotyping, all antisense
primers were biotinylated at their 59end as described [17]. The
amplification conditions were 94uC for 3 min followed by 40
cycles of 94uC, 59uC for 45 s and 68uC for 1 min with a final
extension step at 68uC for 5 min. Sequencing primers for SNP
analysis were used to genotype all PCR products at the codon
positions 167, 198 and 200 in a Pyrosequencer (Biotage AB,
Charlottesville, VA, USA) (Supplementary Table S1). Parasites
genotyped did not necessary come from the same subjects sampled
before and after treatment. Eggs were extracted from as many
hosts as possible, though finding sufficient number post-treatment
was restricted by low egg density. Therefore all eggs, from the
same community or school, were pooled, before analysis of
genotypes of individual eggs. The number of eggs isolated and
genotyped are presented in the flow-chart (Figure 1).
Statistical Analysis
The treatment efficacy on A. lumbricoides, T. trichiura and
hookworms was evaluated by the egg reduction rate (ERR) for
each diagnostic method applied in each country: McMaster (in
Haiti, and Kenya), Kato-Katz (In Kenya and Panama) and
FLOTAC (in Panama). The ERR was calculated, at the group
level, as the ratio of the difference between the arithmetic mean of
the pre- and post-treatment faecal egg count (FEC) to the pre-
treatment arithmetic mean, expressed as a percentage, i.e.
ignoring individual variability [25]. The negative individuals at
baseline were still sampled at the post-treatment collection and the
resulting data were included for the calculation of ERR.
Uninfected subjects were included in the mean of the FEC.
Confidence intervals of each ERR estimate were determined using
a bootstrap resampling method (with replacement) over 10,000
replicates in R (version 2.15.0, Vienna Austria, http://www.R-
project.org).
Genotype frequencies of SNPs at positions 167, 198 and 200 in
A. lumbricoides, T. trichiura and hookworms obtained at the pre-
treatment collections were compared with the genotype frequen-
cies of the same SNPs obtained at the post-treatment collections
using Fisher’s exact test within GraphPad Prism (GraphPad
software, San Diego, CA, USA).
Deviation from Hardy-Weinberg equilibrium (HWE) was
analyzed for the b-tubulin gene at position 200 in T. trichiura
using Arlequin version 3.1 software [26], where the p-value was
calculated based on the Markov-chain method [27]. Deviations
from the HWE were not determined for A. lumbricoides or
hookworm for reasons explained below. When a departure from
HWE was observed in T. trichiura, we estimated the maximum
likelihood frequency of a null allele at position 200. This estimate
was calculated using an Expectation-Maximization Algorithm of
Dempster and colleagues [28] (EM Algorithm, http://132.206.
161.123/em.html).
Results
Genotype Frequencies for the b-tubulin Gene in T.
trichiura
In T. trichiura, the three codon positions 167, 198, and 200 were
found to be polymorphic in samples collected from untreated and
treated subjects in Haiti, Kenya, and Panama.
In Haiti we analyzed 65 individual T. trichiura eggs from 30
untreated subjects and 38 from 14 treated subjects. We recorded
11% and 47% experimental failure (includes DNA extraction,
PCR amplification and Pyrosequencing) in pre- and post-
treatment samples, respectively. Before treatment the TRA SNP
Figure 2. Genotype frequencies of the b-tubulin gene position
200 in T. trichiura from Haiti and Kenya. Genotype frequencies of T.
trichura collected in Haiti (A) and in Kenya (B); Number of individual T.
trichiura eggs genotyped according to the available material, in Haiti
was 65 in the untreated group (pre-Tx) and 38 in the treated group
(post-Tx), in Kenya was 40 in the untreated group and 90 in the treated
group. Sequences were diploid, TT indicates the homozygous
susceptible-type TTC/TTC, TA the heterozygous TTC/TAC and AA, the
homozygous resistance-type TAC/TAC; Tx = treatment, *Indicates a
significant difference (p,0.001) in genotype frequency between the
pre- and post treatment groups. P-values were obtained by Fisher’s
exact test.
doi:10.1371/journal.pntd.0002247.g002
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at codon position 200 (SNP200) was identified at low frequency;
3.1% of individual eggs genotyped were homozygous resistance-
type (AA) and 23.1% were heterozygous (TA). After treatment,
there was a significant increase in the frequency of the
homozygous resistance-type, from 3.1% to 55.3% (p,0.001),
and a statistically significant decrease of the homozygous
susceptible-type, from 75.4% to 21.1% (p,0.0001) (Figure 2A).
The ARC SNP at codon position 198 was also found and showed
a statistically significant change in frequency following treatment.
However, the changes at codon 198 were less pronounced than at
codon 200. After treatment, there was a significant increase of
homozygous resistant-type from 3.1% to 13.2% (p,0.001), and a
significant decrease of homozygous susceptible-type from 73.8% to
63.2% (Figure 3).
In Kenya, 40 individual T. trichiura eggs from 20 untreated
subjects and 90 eggs from 31 treated subjects were genotyped. We
recorded 30% and 5% experimental failure in pre- and post-
treatment samples, respectively. Only the codon 200 SNP was
polymorphic. The same trend observed in Haiti was seen with a
statistically significant increase, from 51.3% to 68.5% (p = 0.019)
of homozygous resistance-type, and a significant decrease, from
48.6% to 21.4% (p = 0.019) of homozygous susceptible-type after
treatment (Figure 2B).
In Panama we genotyped 19 ‘‘pre-treatment’’ T. trichiura eggs
from 10 subjects, which were collected 9 months after an earlier
treatment, and 49 post-treatment eggs from 21 subjects collected 3
weeks after this second ABZ treatment. We observed homozygous
resistance-type (78.9%) and homozygous susceptible-type (21.1%),
at codon 167, in the pre-treatment collection. For codons 198 and
200, 84% of the pre-treatment T. trichiura egg samples failed the
PCR amplification and therefore it was not possible to assess the
genotype frequencies for these positions. At the post-treatment
collection, the codon 167 polymorphism was still present in the
treatment survivors as homozygote resistance-type in 16.3% of
individual eggs genotyped. For codons 198 and 200, we observed a
predominance of homozygous susceptible-type genotypes, 97.6%
and 88.1% respectively; and a low frequency of heterozygous,
2.4% (for each position) and homozygous resistance-type, 9.5%
(for codon 200).
Genotype Frequencies of b-tubulin Gene Positions 167,
198 and 200 in A. lumbricoides
In A. lumbricoides, the codon position 167 of the b-tubulin gene
was polymorphic in parasites collected from untreated and treated
subjects in Haiti, Kenya and Panama, whereas the codon positions
198 and 200 were monomorphic. The SNP at position 167
identified was confirmed by conventional Sanger sequencing and
real time PCR (data not shown).
In Haiti, we genotyped 37 individual A. lumbricoides eggs from 13
untreated subjects and five eggs from three treated subjects. We
recorded 49% and 28% experimental failure in pre- and post-
treatment samples. Prior to treatment, homozygous resistance-type
(40%) and heterozygous (60%), at codon 167, were present in the
population; however, only heterozygotes were detected after
treatment.
In Kenya, 22 individual A. lumbricoides eggs from 6 untreated
subjects and 19 eggs from 4 treated subjects were genotyped. We
recorded 15% and 17% experimental failure in pre- and post-
treatment samples, respectively. The predominant genotype
frequency identified was the homozygous resistance-type (72.7%)
at codon 167. After treatment, there was no significant difference
in the homozygous resistance-type frequency; however, as
observed in A. lumbricoides collected in Haiti, at codon 167 there
was a statistically significant increase of heterozygotes from 4.5%
to 21.1% (p,0.001), and also a significant decrease of homozy-
gous susceptible-type from 22.7% to 5.3% (p,0.001).
In Panama, 53 individual eggs were genotyped from 28
untreated subjects and 70 eggs from 20 treated subjects. We
recorded 57% of experimental failure only in pre-treatment
samples. As seen previously in Haiti and Kenya, the most
abundant genotype at codon 167 was homozygous resistance-type
(97.7%). In this population the lowest genotype frequency was
identified as homozygous susceptible-type (2.3%). After treatment,
the percentage of both genotypes did not change significantly
(96.7% and 3.2%, respectively) (Table 1).
Genotype Frequencies of b-tubulin Gene Positions 167,
198 and 200 in Hookworms
In hookworms, the codons 167 and 198 of the b-tubulin gene
were monomorphic in all samples genotyped from Haiti, Kenya
and Panama. Codon 200 polymorphism (TAC) was detected in 2
eggs collected in Kenya. In Kenya, 86 individual eggs from 28
untreated subjects and 127 eggs from 34 treated subjects were
genotyped. We recorded 19% and 4% experimental failure in pre-
and post-treatment samples, respectively. In the pre-treatment
collection we identified homozygous resistance-type at low
frequency (2.3%) and a predominance of homozygous suscepti-
ble-type (97.7%). After treatment the frequencies did not change
significantly. In Haiti, we examined 84 hookworm eggs from 31
untreated subjects and 14 from five treated subjects and we did not
identify any polymorphism at the SNP sites of interest. We
recorded 19% and 63% of experimental failure for the samples
from the pre- and post-treatment, respectively. In Panama, all 23
eggs analyzed from nine untreated subjects and 59 from 29 treated
subjects were homozygous susceptible-type for all three positions.
We recorded 71% and 24% of experimental failure for the
samples from the pre- and post-treatment, respectively.
Figure 3. Genotype frequencies of the b-tubulin gene position
198 in T. trichiura from Haiti before and after ABZ treatment.
Genotype frequencies of T. trichura collected in Haiti. The number of
individual T. trichiura eggs genotyped, according to the available
material, was 65 in the untreated group (pre-Tx) and 38 in the treated
group (post-Tx). Sequences were diploid, AA indicates the homozygous
susceptible-type GAA/GAA, AC the heterozygous GAA/GCA and CC, the
homozygous resistance-type GCA/GCA; Tx = treatment, *Indicates a
significant difference (p,0.001) in genotype frequency between the
pre- and post treatment groups. P-values were obtained by Fisher’s
exact test.
doi:10.1371/journal.pntd.0002247.g003
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Drug Efficacy
The arithmetic means of the faecal egg count (FEC) per gram
are presented in Table 2. The standard error of the mean obtained
shows a high variability of the FEC in the treated and untreated
populations.
The ERR estimates calculated for A. lumbricoides, T. trichiura and
hookworms for each diagnostic test applied in Haiti, Kenya and
Panama are summarized in Table 2. The ERR from the same
country estimated using two different diagnostic methods are not
directly comparable as the number of samples tested (and
therefore the hosts making up the ERR) were different. A direct
comparison of the different diagnostic methods per se is beyond the
scope of this paper and has been previously discussed elsewhere
[29,30]. In Haiti where only McMaster was applied, the ERR for
A. lumbricoides was the highest (99.9% (95% CI 99.5–100.0))
followed by hookworms (98.6% (95% CI 96.1–99.7)) and T.
trichiura (49.7% (95% CI 0.0–88.4)). In Kenya the ERR estimates
differed between the Kato-Katz and McMaster methods. The
highest ERR was obtained for hookworms, with Kato-Katz at
89.95% (95% CI, 0.0–96.1%) and McMaster at 96.8% (95% CI,
92.5–99.2%). This was followed by A. lumbricoides with 97.3% (95%
CI, 0.0–100.0%) and 80.3% (95% CI, 0.0–100.0%), respectively,
and finally by T. trichiura with 86.8% (95% CI, 0.0–98.7%) and
10.1% (95% CI, 0.0–78%). The ERR estimate based on Kato-
Katz was the one considered as the sample sizes available were
much higher (n = 104 and n = 92 at pre- and post-treatment,
respectively) than those for McMaster (n = 24 and n = 42 at pre-
and post-treatment, respectively). In Panama, the ERR estimates
for FLOTAC were the ones considered as the number of samples
analyzed was greater than those counted by Kato-Katz [19]. In
Panama, the highest ERR estimate was for A. lumbricoides, at 89.8%
(95% CI, 75.8–97.3%), followed by T. trichiura with 65.1% (95%
CI, 0–89.1%), and finally by hookworms with 47.8% (95% CI, 0–
89.9%).
Hardy-Weinberg Equilibrium
Guo’s Exact Hardy-Weinberg test [27] showed that there was a
significant departure from Hardy-Weinberg expectations recorded
in T. trichiura collected in Haiti (p = 0.0366) after treatment, and in
Kenya before and after treatment (p,0.0001) for position 200 of
the b-tubulin. This disequilibrium was characterized by a
deficiency in the number of heterozygotes (Table 3). The
estimated frequency of a null allele at position 200 showed no
evidence (x2 = 3.69) that a null allele was responsible of the paucity
of heterozygotes. For positions, 167 and 198, respectively,
polymorphism was either not found, or the differences between
the frequencies of heterozygotes pre- and post-treatment were not
significant.
Discussion
One of the main findings of this study was the identification of a
SNP at position 200 in T. trichiura samples collected in Haiti and
Kenya at the pre-treatment collections. Thus, these findings
suggest that the resistance-type allele (TAC200) already existed in
these populations prior to ABZ treatment. This result was
consistent with a previous report in which the codon 200
polymorphism was identified in adult T. trichiura from Kenya in
an ABZ-naı¨ve population [17]. This SNP was also present in
human filarial nematodes from Burkina Faso, in samples obtained
from pre-treatment patients at a moderate allele frequency (26.2%)
[31].
However, it must be taken into consideration that ABZ is a
commonly used AH in endemic countries, and yearly school-based
helminth control programmes relying on ABZ and MBZ are also
common in countries where our studies were performed [32–34].
Indeed, in Kenya, six months prior to our study, children from the
selected schools had been treated with ABZ in the context of the
LF control programme. In Panama, at the baseline collection (nine
months earlier), the codon 200 polymorphism was identified (data
not shown), and in a previous study carried out in the same region,
the same SNP had been detected in T. trichiura [17]. Finally, in
Haiti, in the context of the LF control programme, ABZ is widely
distributed yearly in combination with DEC at the community
level, in surrounding communities [32]. So, it may be possible that
some participants in Panama or Haiti from the studied populations
had travelled to treated areas or could have been infected with
eggs from family members who had been previously treated with
ABZ. Thus, it may be possible that parasites have been previously
exposed to the drug and that some selection for the SNPs at codon
position 200 had occurred prior to the beginning of MDA for
STHs, or that in Kenya, selection at codon 200 may have
developed following the previous rounds of ABZ treatment in the
population.
Other findings were the identification of SNPs in T. trichiura at
codon 167 in samples from Panama and at codon 198 in samples
from Haiti and Kenya, prior to treatment. The identification of
the same resistance-type allele at codon 198, in populations that
are geographically separated suggests that this allele could be
Table 1. Genotype frequencies of b-tubulin position 167 in A. lumbricoides before and after ABZ treatment.
Frequency (%)
Haiti Kenya Panama
Genotypes Pre-Tx4 (n =37) Post-Tx (n =5) Pre-Tx (n =22) Post-Tx (n =19) Pre-Tx (n =53) Post-Tx (n =70)
TT1 22.7a 5.3a
TA2 60 100.0 4.5b 21.1b 2.3 3.2
AA3 40 72.7 73.7 97.7 96.8
1TT =homozygous susceptible-type TTC/TTC.
2TA =heterozygous TTC/TAC.
3AA=homozygous resistance-type type TAC/TAC.
4Tx = treatment.
The numbers in parentheses indicate the number of individual eggs genotyped. The letters (a,b) indicate significant difference (p,0.001) between the genotypes of the
pre- and post treatment groups.
P-values were obtained from Fisher’s exact test.
doi:10.1371/journal.pntd.0002247.t001
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common in T. trichiura populations, even prior to ABZ treatment.
However, the frequency of the resistance-type allele at codon 198,
and the identification of the resistance-type allele at codon 167 in
only one country suggest that these polymorphisms are less
common than the codon 200 polymorphism. In the veterinary
parasitic nematode Haemonchus contortus, it has been confirmed that
the codon 200 polymorphism, which causes BZ resistance, is the
predominant SNP associated with resistance, compared to the
codon 167 polymorphism [13], or the codon 198 polymorphism
[12,15]. In addition, it was also interesting to note that the codon
167 polymorphism was always found alone and never associated
with the SNPs at positions 198 and 200. This is consistent with
observations made in H. contortus suggesting that the polymorphism
at position 167 (TAC) does not occur in the same allele as the
polymorphism at position 200 (TAC) or 198 (GCA) [12,15].
The post-treatment examination of the resistance-type allele
frequencies of T. trichiura collected in the three different
geographical areas suggests that ABZ may be selectively eliminat-
ing worms carrying susceptible-type alleles and allowing worms
with the resistance-type alleles to survive treatment. Indeed, in
Haiti and Kenya one round of treatment significantly increased
the frequency of the homozygous resistance-type at codon position
200 (TAC/TAC200) and some heterozygote eggs (TTC/TAC200)
were also found after treatment. It was also found that the codon
198 polymorphism persisted after one treatment but at lower
frequency compared to the codon 200 polymorphism. Thus, our
results suggest that ABZ treatment could select for parasites
harbouring the codon 200 (TAC) polymorphism. We tested
whether the genotype frequencies of the b-tubulin gene at codon
200 obtained before and after treatment were in HWE. In Haiti,
the increase of the homozygous resistance-type after treatment, for
codon position 200, correlated with a departure from HWE
illustrated by a paucity of heterozygotes and an excess of
homozygotes. In Kenya, the b-tubulin at position 200 in T.
trichiura was not in HWE before treatment as there was an excess of
homozygotes. Different hypotheses may explain the HWE
imbalance in genotype frequencies; one possible cause could be
selection acting on the parasite populations.
The above data strongly suggest that the SNP at b-tubulin
codon 200 may be responsible for the intermediate efficacy of ABZ
against T. trichiura, where the ERR ranged from 10.1% (Kenya) to
65% (Panama). A poor efficacy of ABZ against T. trichiura has been
repeatedly observed across a number of different studies [35]. In
addition, it is not uncommon to find considerable variation of
ERR estimates (ranging from 0 to 90%) in the literature [36],
which, in addition to being explained by the use of different
diagnostic methods (see above), is in agreement with the high
resistance-type allele frequencies observed at loci 200 and 198 in
Haiti and Kenya. If drug susceptibility is determined (in part) by
these alleles, then AH resistance might develop relatively quickly
in locations such as these. Resistance to BZ drugs is usually
recessive [11] so high allele frequencies are required to generate
the phenotypic diversity that leads to the poor drug efficacy that
has been recorded.
Another finding of the study was the identification of the
resistance-type SNP (based on comparison with studies in some
veterinary nematodes), at codon position 167 in A. lumbricoides
before and after treatment. In A. lumbricoides collected in Haiti,
Kenya and Panama, the allele containing TAC at codon 167 was
identified as homozygous at high frequency prior to ABZ
treatment. The post-treatment genotype frequencies indicated
that ABZ treatment did not change the frequency of the
homozygous, resistance-type, codon 167 in Kenya and Panama,
where sample sizes were similar, and heterozygotes remained in
the population surviving treatment. It was also interesting to note
that similar findings have been published for the veterinary
parasitic nematode, Teladorsagia circumcincta [13]. In this case, it was
demonstrated that BZ treatment did not change the frequency of
the homozygous, resistance-associated codon 167 or that of
heterozygotes. In a recent study, it was also found that H. contortus
heterozygous at codon 167 were associated with susceptible
phenotypes [15]. In contrast, in Haiti where the sample sizes were
highly different between the pre- and post-treatment groups, we
found that the resistance-type genotype frequency of A. lumbricoides
at codon position 167 significantly increased after treatment, but
the small sample size at the post-treatment collection made it
difficult to draw clear conclusions.
The genetic data from A. lumbricoides suggest that the polymor-
phism at codon position 167 is common and may be naturally
present. However, ERR estimates indicate that treatment was
successful according to WHO standardized thresholds [37]. This
implies that in A. lumbricoides, the mutation at codon position 167
may not have an impact on drug efficacy. In contrast, in intestinal
trichostrongylid nematodes of livestock (e.g., H. contortus), the SNP
167 is rarely encountered but the homozygous allele containing
TAC does confer BZ resistance in some species [38,39]. It is also
common in these species to have SNP associations between codons
167 and 200 that could confer high levels of BZ resistance [15].
It was interesting to find that in A. lumbricoides, all eggs
genotyped were susceptible-types at codon positions 198 and
200. It is possible that should polymorphisms be found at codons
200 or 198 in A. lumbricoides, these polymorphisms may change the
sensitivity of the parasite to the drug as has been described in
veterinary parasites [12,15]. It will be informative to investigate
the b-tubulin gene of A. lumbricoides in areas where MDA has been
implemented to determine whether the position 200 is ever
polymorphic and whether it correlates with drug response.
Finally, the b-tubulin analysis in hookworms, at codon 200, 167
and 198, revealed the presence of a SNP at codon 200 in samples
collected in Kenya at pre- and post-treatment. However, the
frequency was very low and the ERR indicated a value consistent
with ABZ treatment being successful. In other studies in which a
Table 3. Observed (HO) and expected (HE) heterozygosity tested under HWE for SNP 200 in T. trichiura.
Pre- treatment Post- treatment
n1 HO HE p-value n HO HE p-value
Haiti 65 0.25 0.24 1.00 38 0.26 0.43 0.0366*
Kenya 40 0.15 0.50 ,0?0001* 90 0.8 0.38 ,0?0001*
1n = sample size.
*Indicates a significant p-value; p-values were obtained from Guo’s exact test.
doi:10.1371/journal.pntd.0002247.t003
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reduced drug efficacy was detected polymorphism at codons 200
and 167 was not detected [40,41].
The main limitation of the present study was the non
homogeneity of the study designs in Haiti, Kenya and Panama.
Indeed, the samples and data on response to treatment were
obtained as part of different collaborations with ongoing treatment
protocols rather than being designed specifically for our study. As
such it was not possible to standardize the methods used for egg
count estimations and exact time samples were taken after
treatment. Furthermore, the studied populations were different
in the three studies. In Panama and Kenya it was restricted to pre-
school and school age children whereas in Haiti, adults and
children were sampled. Furthermore, three diagnostic methods
have been applied to quantify STHs. Resulting drug efficacies
were variable within the same country, depending on the
techniques and sample sizes. In another study, the McMaster
and Kato-Katz gave similar results for the ERR [25]. It is
important to mention that the sample sizes were different for the
two diagnostic tests when performed in the same country. Our
goal was not to compare test sensitivity for quantifying egg counts.
The results reported here should be viewed as those arising from
three different field treatment studies in which we used procedures
to assess genotype and have compared the genotypes with
assessments of ERR for each of the three separate treatment
studies, observed with different methods and sampling schedules.
As such the ERR results between the studies should not be
compared; what was relevant for our investigations was the
assessment of ERR by one or more conventional parasitological
methods with the genotype determination for samples from the
same communities.
The other limitation of the study was the low sample size of
individual eggs genotyped due to a high percentage of PCR
failure. This was caused by the difficulty in amplifying the DNA of
individual eggs, possibly due to the presence of inhibitors from
faeces that could prevent the DNA extraction [42]. Also, the low
DNA concentration may have affected the success of the DNA
amplification and pyrosequencing. In T. trichiura eggs from
Panama, we recorded more DNA amplification failure for
positions 198–200 than for position 167. One of the primers used
to amplify the sequence around the codons 198 and 200 was in
part in an intron. Polymorphism in this intron may have resulted
in poor amplification in some samples. However, the samples that
were successfully genotyped allowed identification of SNPs in T.
trichiura which may be associated with the ability of worms to
survive ABZ treatment. These results stress the importance of
implementing, as integral part of MDA programmes, regular
monitoring of drug efficacy and associated parasite genetics for
prompt detection of drug resistance.
In this study, we estimated the ERR at the group level; it is a
more accurate estimation of overall ERR because it can include
negative individual values. The estimation of the ERR on a group
basis by bootstrapping gave a range of [0–89%] in hookworms,
whereas when estimated by Halpenny and colleagues [19] on
individual basis the ERR was 89%.
Likewise, there is an urgent need to consider control strategies
that will maintain a low resistance-type SNP prevalence and a high
drug efficacy. Strategies have been described to maintain a high
level of STH control while also delaying the possible development
of drug resistance [7]. Drug combination has been used to combat
the problem of AH resistance in veterinary parasites and human
parasites [43,44]. The pros and cons of various combinations
should be carefully considered so that the chosen combination will
have both a positive impact on drug efficacy and on a reduction of
genetic selection for resistance.
Conclusion and Future Directions
Comparable data on pre- and post-treatment SNP frequencies
were obtained at the different study sites, despite differences in the
study designs between sites. However, in the context of monitoring
and surveillance of STH control programmes, it will be important
to conduct multiple studies according to standardized multi-centre
protocols in order to allow drug efficacies to be compared.
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